Birdwatch Archive

Birdwatch Note

2024-02-20 14:33:11 UTC - MISINFORMED_OR_POTENTIALLY_MISLEADING

学術的に多数の研究の統合評価は質の高い研究のメタ解析で行い↓研究数の計数ではない事に注意が必要です。 https://ja.wikipedia.org/wiki/%E3%83%A1%E3%82%BF%E3%82%A2%E3%83%8A%E3%83%AA%E3%82%B7%E3%82%B9 例えば福島氏が用いたコロナワクチン、副作用の語を基本にした検索方法は単純なpubmed検索では1600件ヒットしますが↓ https://x.gd/nYTBB BCGでも750件ヒットします↓ https://x.gd/cbvMH また氏があげた多数の研究有との疾患(↓表3)は http://cont.o.oo7.jp/51_3/w43.pdf 頭痛、心筋炎、リンパ節腫大、アナフィラキシーの様に当局より以前より周知されているリスク、副反応であったり↓ https://www.cov19-vaccine.mhlw.go.jp/qa/0002.html ギランバレーや血栓症はベクターワクチンでのみメタ解析で未接種より高リスクだった↓事に注意が必要です https://link.springer.com/article/10.1007/s00415-024-12186-7 (下記3.4.2) https://www.mdpi.com/2076-393X/10/4/596

Written by F4D2E4CA66E08B99BDDE8328BBF4C2313B853B3595C8AC38600E463328C72D9D
Participant Details

Original Tweet

Tweet embedding is no longer reliably available, due to the platform's instability (in terms of both technology and policy). If the Tweet still exists, you can view it here: https://twitter.com/foo_bar/status/1759932589425729796

Please note, though, that you may need to have your own Twitter account to access that page. I am currently exploring options for archiving Tweet data in a post-API context.

All Information

  • ID - 1759949321040986214
  • noteId - 1759949321040986214
  • participantId -
  • noteAuthorParticipantId - F4D2E4CA66E08B99BDDE8328BBF4C2313B853B3595C8AC38600E463328C72D9D Participant Details
  • createdAtMillis - 1708439591075
  • tweetId - 1759932589425729796
  • classification - MISINFORMED_OR_POTENTIALLY_MISLEADING
  • believable -
  • harmful -
  • validationDifficulty -
  • misleadingOther - 0
  • misleadingFactualError - 1
  • misleadingManipulatedMedia - 1
  • misleadingOutdatedInformation - 0
  • misleadingMissingImportantContext - 1
  • misleadingUnverifiedClaimAsFact - 1
  • misleadingSatire - 0
  • notMisleadingOther - 0
  • notMisleadingFactuallyCorrect - 0
  • notMisleadingOutdatedButNotWhenWritten - 0
  • notMisleadingClearlySatire - 0
  • notMisleadingPersonalOpinion - 0
  • trustworthySources - 1
  • summary
    • 学術的に多数の研究の統合評価は質の高い研究のメタ解析で行い↓研究数の計数ではない事に注意が必要です。 https://ja.wikipedia.org/wiki/%E3%83%A1%E3%82%BF%E3%82%A2%E3%83%8A%E3%83%AA%E3%82%B7%E3%82%B9 例えば福島氏が用いたコロナワクチン、副作用の語を基本にした検索方法は単純なpubmed検索では1600件ヒットしますが↓ https://x.gd/nYTBB BCGでも750件ヒットします↓ https://x.gd/cbvMH また氏があげた多数の研究有との疾患(↓表3)は http://cont.o.oo7.jp/51_3/w43.pdf 頭痛、心筋炎、リンパ節腫大、アナフィラキシーの様に当局より以前より周知されているリスク、副反応であったり↓ https://www.cov19-vaccine.mhlw.go.jp/qa/0002.html ギランバレーや血栓症はベクターワクチンでのみメタ解析で未接種より高リスクだった↓事に注意が必要です https://link.springer.com/article/10.1007/s00415-024-12186-7 (下記3.4.2) https://www.mdpi.com/2076-393X/10/4/596

Note Status History

createdAt timestampMillisOfFirstNonNMRStatus firstNonNMRStatus timestampMillisOfCurrentStatus currentStatus timestampMillisOfLatestNonNMRStatus mostRecentNonNMRStatus participantId
2024-02-20 14:33:11 UTC
(1708439591075)
2024-02-21 04:10:14 UTC
(1708488614531)
CURRENTLY_RATED_HELPFUL 2024-02-21 09:05:56 UTC
(1708506356169)
CURRENTLY_RATED_HELPFUL 2024-02-21 04:10:14 UTC
(1708488614531)
CURRENTLY_RATED_HELPFUL

Note Ratings

rated at rated by
2024-02-20 19:02:55 -0600 Rating Details
2024-02-20 18:46:01 -0600 Rating Details
2024-02-20 17:28:26 -0600 Rating Details
2024-02-20 17:10:35 -0600 Rating Details
2024-02-20 15:40:22 -0600 Rating Details
2024-02-20 15:08:28 -0600 Rating Details
2024-02-20 12:16:20 -0600 Rating Details
2024-02-20 12:02:21 -0600 Rating Details
2024-02-20 10:44:08 -0600 Rating Details
2024-02-20 10:31:40 -0600 Rating Details
2024-02-20 09:37:26 -0600 Rating Details
2024-02-20 08:52:41 -0600 Rating Details
2024-02-20 08:47:24 -0600 Rating Details
2024-02-20 08:42:47 -0600 Rating Details
2024-02-21 06:50:02 -0600 Rating Details
2024-02-21 02:10:29 -0600 Rating Details
2024-02-22 18:45:07 -0600 Rating Details
2024-02-22 17:57:25 -0600 Rating Details
2024-02-24 08:49:03 -0600 Rating Details
2024-02-22 04:13:40 -0600 Rating Details
2024-02-21 10:14:41 -0600 Rating Details
2024-02-20 21:09:04 -0600 Rating Details
2024-02-20 18:46:03 -0600 Rating Details
2024-02-20 18:28:08 -0600 Rating Details
2024-02-20 18:06:12 -0600 Rating Details
2024-02-20 17:56:51 -0600 Rating Details
2024-02-20 16:43:40 -0600 Rating Details
2024-02-20 15:18:21 -0600 Rating Details
2024-02-20 15:10:39 -0600 Rating Details
2024-02-20 11:47:16 -0600 Rating Details
2024-02-20 11:40:48 -0600 Rating Details
2024-02-20 10:20:44 -0600 Rating Details
2024-02-20 09:38:52 -0600 Rating Details
2024-02-20 09:17:30 -0600 Rating Details
2024-02-20 09:04:32 -0600 Rating Details
2024-02-20 08:45:26 -0600 Rating Details
2024-02-20 08:45:24 -0600 Rating Details
2024-02-20 08:45:17 -0600 Rating Details
2024-02-20 08:42:16 -0600 Rating Details
2024-02-22 12:03:00 -0600 Rating Details
2024-02-22 03:59:55 -0600 Rating Details
2024-02-20 18:36:17 -0600 Rating Details
2024-02-20 18:08:31 -0600 Rating Details
2024-02-20 16:23:43 -0600 Rating Details
2024-02-20 15:47:11 -0600 Rating Details
2024-02-20 15:16:08 -0600 Rating Details
2024-02-20 15:10:01 -0600 Rating Details
2024-02-20 15:00:28 -0600 Rating Details
2024-02-20 14:28:54 -0600 Rating Details
2024-02-20 12:48:30 -0600 Rating Details
2024-02-20 11:13:47 -0600 Rating Details
2024-02-20 10:31:02 -0600 Rating Details
2024-02-20 09:58:03 -0600 Rating Details
2024-02-20 09:27:43 -0600 Rating Details
2024-02-20 09:13:59 -0600 Rating Details
2024-02-20 08:39:28 -0600 Rating Details